Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1

Oral Oncol. 2019 Jan:88:115-123. doi: 10.1016/j.oraloncology.2018.11.002. Epub 2018 Nov 23.

Abstract

Objectives: Crosstalk between cancer cells and carcinoma-associated fibroblasts (CAFs) is known to be involved in various aspects of tumor biology, including during invasion. Using oral squamous cell carcinoma (OSCC) cells as a model, we examined whether and how CAFs respond to inflammatory signals to influence cancer cell migration and invasion.

Materials and methods: Chemokine signatures within the human HNSCC datasets from The Cancer Genome Atlas (TCGA) were analyzed together with tissue assessment using immunohistochemical staining (IHC) and real-time PCR. A co-culture system was used to identify reciprocal effects exerted by CAFs and cancer cells upon one another. Recombinant CXCL1, CXCL1 neutralizing antibodies, and CXCR2 antagonist were used to confirm CXCL1/CXCR2 axis-mediated cell behaviors.

Results: Analysis of the TCGA dataset revealed that CXCL1 is associated with poor survival, and IHC demonstrated CXCL1 is highly expressed in OSCC stromal cells. Moreover, real-time PCR showed that in addition to CXCL1, IL-1β and CXCR2 are also highly expressed in OSCC and IL-1β mRNA levels positively correlate with CXCL1 expression. Furthermore, CAFs co-cultured with SAS, a poorly differentiated OSCC cell line, or stimulated with IL-1β exhibit increased CXCL1 secretion in an NF-κB-dependent manner. Treatment of SAS cells with CAF-conditioned medium or CXCL1 increased their invasion and migration capabilities, indicating a reciprocal activation between CAFs and cancer cells. Moreover, CXCL-1 upregulated matrix metalloprotease-1 (MMP-1) expression and activity in CAFs.

Conclusion: The induction of IL-1β following CXCL1 stimulation of CAFs mediates cancer cell invasion, and there is a reciprocal dependency between CAFs and cancer cells in the OSCC microenvironment.

Keywords: CXCL1; Cancer-associated fibroblasts; IL-1β; Matrix metalloproteinase 1; Neoplasm invasiveness; Oral squamous cell carcinoma; Survival rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Cancer-Associated Fibroblasts / metabolism*
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology*
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Chemokine CXCL1 / genetics
  • Chemokine CXCL1 / immunology
  • Chemokine CXCL1 / metabolism*
  • Coculture Techniques
  • Culture Media, Conditioned
  • Humans
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • Interleukin-1beta / pharmacology
  • Matrix Metalloproteinase 1 / metabolism
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology*
  • Neoplasm Invasiveness
  • Paracrine Communication*
  • Phenylurea Compounds / pharmacology
  • Progression-Free Survival
  • Receptors, Interleukin-8B / antagonists & inhibitors
  • Receptors, Interleukin-8B / genetics
  • Tumor Microenvironment

Substances

  • Antibodies, Monoclonal
  • CXCL1 protein, human
  • CXCR2 protein, human
  • Chemokine CXCL1
  • Culture Media, Conditioned
  • IL1B protein, human
  • Interleukin-1beta
  • Phenylurea Compounds
  • Receptors, Interleukin-8B
  • SB 225002
  • MMP1 protein, human
  • Matrix Metalloproteinase 1